Orphan Drugs

Pharmaceutical Market Access in Developed Market is now pre-order on Amazon!!

The book titled as “Pharmaceutical Market Access in Developed Markets” under Dr. Guvenc Kockaya (CarthaGenetics market Access Director) and Prof. Albert Wert heimer’s editorialship has been published for pre-order on Amazon.

Market access is the process by which a pharmaceutical company gets its product available on the market after having obtained a marketing authorization from a regulatory agency and by which the product becomes available for all patients for whom it is indicated as per its marketing authorization. Since there are cultural differences among countries, any Market Access strategy needs to be culturally sensitive. Pharmaceutical Market Access in emerging markets has been extensively discussed in the previous book, published in 2016. The present book focuses on developed markets with the goal of helping students, academics industry personnel and government workers and decision makers understand the environment in developed markets.

https://www.amazon.com/Pharmaceutical-Market-Access-Deve…/…/